Rekombinanter CD40 Antikörper (Extracellular Domain)
Kurzübersicht für Rekombinanter CD40 Antikörper (Extracellular Domain) (ABIN7072684)
Target
Alle CD40 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - Extracellular Domain
 - 
                                            
Verwendungszweck
 - Anti-CD40 [chi220], Mouse IgG2a, kappa
 - 
                                            
Spezifität
 - This antibody binds the CD40 and blocks the humoral immune responses to T cell dependent antigens in a dose dependent manner.
 - 
                                            
Produktmerkmale
 - 
                        
Original Species of Ab: Mouse
Original Format of Ab: IgG2a
 - 
                                            
Aufreinigung
 - Protein A affinity purified
 - 
                                            
Immunogen
 - This antibody was generated by immunizing female BALB/c mice with a fusion protein containing extracellular domain of human CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.
 - 
                                            
Isotyp
 - IgG2a kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - This antibody blocks the interaction between CD40 and gp39. Chi220 was used either alone or in combination with CTLA4-Ig in an immunosuppresive therapy study to check the survival of renal allografts in non human primate models (PMID: 12394833). Chi220 blocks binding of CD154, it also has partial agonist properties and weak stimulatory potential. It synergisticaly works with LEA29Y (belatacept) to prolong the islet allograft survival in a non-human primate Macaca fascicularis (PMID: 15611281). A study on protection of islets xenographs in diabetic macaques used a combination of Chi220 with IL-2 receptor specific antibody Basiliximab for immunosuppression with induction therapy. Chi220 is used as an sCD154 blocking agent and it was seen that it binds sCD154 in a dose dependant manner (PMID: 21920020). Two humanized versions of this antibody were generated F4 and L3.17, also showed similar properties. Humanized versions of this antibody are available on request.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Konzentration
 - 1 mg/mL
 - 
                                            
Buffer
 - PBS with 0.02 % Proclin 300.
 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
 
 - 
                                            
 - 
    
- CD40
 - 
                                            
Andere Bezeichnung
 - CD40
 - 
                                            
Hintergrund
 - TNFSF5, CDw40, TRAP, p50, Bp50, CD40L receptor, Tumor necrosis factor ligand superfamily member 5, B-cell surface antigen CD40, T-cell antigen Gp39, TNF-related activation protein.
 - 
                                            
UniProt
 - P29965
 - 
                                            
Pathways
 - NF-kappaB Signalweg, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
 
Target
 -